Cargando…
The advantages of UK Biobank's open‐access strategy for health research
Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790705/ https://www.ncbi.nlm.nih.gov/pubmed/31283063 http://dx.doi.org/10.1111/joim.12955 |
_version_ | 1783458829009158144 |
---|---|
author | Conroy, M. Sellors, J. Effingham, M. Littlejohns, T. J. Boultwood, C. Gillions, L. Sudlow, C. L. M. Collins, R. Allen, N. E. |
author_facet | Conroy, M. Sellors, J. Effingham, M. Littlejohns, T. J. Boultwood, C. Gillions, L. Sudlow, C. L. M. Collins, R. Allen, N. E. |
author_sort | Conroy, M. |
collection | PubMed |
description | Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the causes, treatment and prevention of many different diseases. UK Biobank has been established as an open‐access resource for public health research, with the intention of making the data as widely available as possible in an equitable and transparent manner. Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. As a consequence, it has enabled scientists to perform world‐leading collaborative research. Moreover, open access to an already deeply characterized cohort has encouraged both public and private sector investment in further enhancements to make UK Biobank an unparalleled resource for public health research and an exemplar for the development of open‐access approaches for other studies. |
format | Online Article Text |
id | pubmed-6790705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67907052019-10-21 The advantages of UK Biobank's open‐access strategy for health research Conroy, M. Sellors, J. Effingham, M. Littlejohns, T. J. Boultwood, C. Gillions, L. Sudlow, C. L. M. Collins, R. Allen, N. E. J Intern Med Reviews Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the causes, treatment and prevention of many different diseases. UK Biobank has been established as an open‐access resource for public health research, with the intention of making the data as widely available as possible in an equitable and transparent manner. Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. As a consequence, it has enabled scientists to perform world‐leading collaborative research. Moreover, open access to an already deeply characterized cohort has encouraged both public and private sector investment in further enhancements to make UK Biobank an unparalleled resource for public health research and an exemplar for the development of open‐access approaches for other studies. John Wiley and Sons Inc. 2019-08-02 2019-10 /pmc/articles/PMC6790705/ /pubmed/31283063 http://dx.doi.org/10.1111/joim.12955 Text en © 2019 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Conroy, M. Sellors, J. Effingham, M. Littlejohns, T. J. Boultwood, C. Gillions, L. Sudlow, C. L. M. Collins, R. Allen, N. E. The advantages of UK Biobank's open‐access strategy for health research |
title | The advantages of UK Biobank's open‐access strategy for health research |
title_full | The advantages of UK Biobank's open‐access strategy for health research |
title_fullStr | The advantages of UK Biobank's open‐access strategy for health research |
title_full_unstemmed | The advantages of UK Biobank's open‐access strategy for health research |
title_short | The advantages of UK Biobank's open‐access strategy for health research |
title_sort | advantages of uk biobank's open‐access strategy for health research |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790705/ https://www.ncbi.nlm.nih.gov/pubmed/31283063 http://dx.doi.org/10.1111/joim.12955 |
work_keys_str_mv | AT conroym theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT sellorsj theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT effinghamm theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT littlejohnstj theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT boultwoodc theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT gillionsl theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT sudlowclm theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT collinsr theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT allenne theadvantagesofukbiobanksopenaccessstrategyforhealthresearch AT conroym advantagesofukbiobanksopenaccessstrategyforhealthresearch AT sellorsj advantagesofukbiobanksopenaccessstrategyforhealthresearch AT effinghamm advantagesofukbiobanksopenaccessstrategyforhealthresearch AT littlejohnstj advantagesofukbiobanksopenaccessstrategyforhealthresearch AT boultwoodc advantagesofukbiobanksopenaccessstrategyforhealthresearch AT gillionsl advantagesofukbiobanksopenaccessstrategyforhealthresearch AT sudlowclm advantagesofukbiobanksopenaccessstrategyforhealthresearch AT collinsr advantagesofukbiobanksopenaccessstrategyforhealthresearch AT allenne advantagesofukbiobanksopenaccessstrategyforhealthresearch |